Atlas Trials

A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma

Clinical trial NCT03534947 · COMPLETED

Trial details

NCT number
NCT03534947
Sponsor
Melanoma Institute Australia
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Basal Cell CarcinomaBasal Cell Carcinoma of Skin, Site UnspecifiedSkin CancerInvasive Carcinoma
Start date
2019-07-23
Primary completion
2025-03-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.